Celecoxib increases lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Celecoxib increases lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1

Published:2015-10-22 Issue:36 Volume:6 Page:39342-39356
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Schellhorn Melina¹,Haustein Maria¹,Frank Marcus²,Linnebacher Michael³,Hinz Burkhard¹

Affiliation:

1. Institute of Toxicology and Pharmacology, Rostock University Medical Center, Rostock, Germany

2. Electron Microscopy Center, Rostock University Medical Center, Rostock, Germany

3. Section of Molecular Oncology and Immunotherapy, Department of General Surgery, Rostock University Medical Center, Rostock, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research on Ternary Solid Dispersions of Celecoxib with Surfactant: Preparation, Characterization, and Solubility Property;Russian Journal of General Chemistry;2024-01

2. Challenges and Opportunities for Celecoxib Repurposing;Pharmaceutical Research;2023-08-08

3. Antitumor effects of valdecoxib on hypopharyngeal squamous carcinoma cells;The Korean Journal of Physiology & Pharmacology;2022-11-01

4. ICAM-1 on Breast Cancer Cells Suppresses Lung Metastasis but Is Dispensable for Tumor Growth and Killing by Cytotoxic T Cells;Frontiers in Immunology;2022-07-11

5. Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing;Pharmaceuticals;2022-07-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP